Insulet | PODD - Crediti Commerciali

Prezzo Delle Azioni
199.33
Cambio Giornaliero
-4.18 -2.05%
Mensile
-16.33%
Annuale
-20.73%
Q2 Previsione
198.16




Crediti Commerciali Cambiamento Data
Abbott USD 10.4B 166M 2025-09
Align Technology USD 1.1B 2.38M 2025-12
AtriCure USD 66.65M 3.67M 2025-12
Avanos Medical USD 103.8M 7.7M 2025-12
Baxter International USD 2.01B 231M 2025-12
Becton, Dickinson and Co. USD 2.51B 486M 2025-12
Boston Scientific USD 2.83B 13M 2025-09
Cardinal Health USD 13.66B 108M 2025-12
Cooper Companies USD 807.1M 21.9M 2025-12
Dexcom USD 1.28B 167.3M 2025-12
Edwards Lifesciences USD 892.8M 9.8M 2025-09
Eli Lilly USD 19.46B 2.25B 2025-09
Globus Medical USD 743.66M 55.54M 2025-12
ICU Medical USD 180.52M 11.03M 2025-12
Inogen USD 37.09M 4.11M 2024-06
Insulet USD 516.9M 54.7M 2025-12
Integra LifeSciences USD 278.85M 16.69M 2025-12
J&J USD 17.61B 235M 2025-09
Masimo USD 391.9M 36M 2025-12
Medtronic USD 6.36B 30M 2025-12
Merit Medical Systems USD 223.61M 7.9M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Solventum Corp USD 1.18B 8M 2025-12
Stryker USD 4.04B 396M 2025-12
Tandem Diabetes Care USD 165.49M 39.55M 2025-12
Teleflex USD 345.58M 247.07M 2025-12
West Pharmaceutical Services USD 574.4M 50.6M 2025-12
Zimmer Biomet Holdings USD 1.7B 106.1M 2025-12